These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24510469)

  • 41. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is flecainide dangerous in long QT-3 patients?
    Beinart R; Michailidis A; Gurevitz OT; Glikson M
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):143-5. PubMed ID: 19140927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion.
    Turco P; De Simone A; La Rocca V; El Jamal B; Nocerino P; Astarita C; De Matteis C; Messina V; Greco L; Rotunno R; Di Napoli T; Vitale DF; Stabile G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S124-7. PubMed ID: 15683478
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [QT prolongation and induction of torsades de pointe by flecainide. Apropos of a case].
    Wickers F; Haissaguere M; Palussiere J
    Arch Mal Coeur Vaiss; 1988 Oct; 81(10):1283-5. PubMed ID: 3146965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome.
    Pellizzón OA; Kalaizich L; Ptácek LJ; Tristani-Firouzi M; Gonzalez MD
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):95-7. PubMed ID: 17655675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature.
    Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L
    Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation.
    Verrier RL; Belardinelli L
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):276-283. PubMed ID: 32032206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.
    Aliot E; Capucci A; Crijns HJ; Goette A; Tamargo J
    Europace; 2011 Feb; 13(2):161-73. PubMed ID: 21138930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wide Complex Tachycardia in a Patient With a History of Atrial Fibrillation.
    Hegde S; Kumar V
    JAMA Intern Med; 2016 Mar; 176(3):386-8. PubMed ID: 26784121
    [No Abstract]   [Full Text] [Related]  

  • 51. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.
    Falk RH
    Ann Intern Med; 1989 Jul; 111(2):107-11. PubMed ID: 2500880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety of flecainide.
    Tamargo J; Capucci A; Mabo P
    Drug Saf; 2012 Apr; 35(4):273-89. PubMed ID: 22435343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased milk drinking causing flecainide toxicity in an older child.
    Thompson B; Mangat J; Barton C; Hawcutt DB
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22729333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long QT Syndrome Leading to Multiple Cardiac Arrests After Posaconazole Administration in an Immune-Compromised Patient with Sepsis: An Unusual Case Report.
    Panos G; Velissaris D; Karamouzos V; Matzaroglou C; Tylianakis M
    Am J Case Rep; 2016 Apr; 17():295-300. PubMed ID: 27125217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of acute ventricular capture threshold rise associated with flecainide acetate.
    Kang TS; Yoon YW; Park S; Hong BK; Kim D; Kwon HM; Kim HS
    Yonsei Med J; 2006 Feb; 47(1):152-4. PubMed ID: 16502500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flecainide-induced myoclonus.
    Velasco SL; Sierra-Hidalgo F; Rodríguez RM; Guerreo AJ; Morales JR
    Clin Neuropharmacol; 2014; 37(2):65-6. PubMed ID: 24614665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome.
    Dautova Y; Zhang Y; Sabir I; Grace AA; Huang CL
    Pflugers Arch; 2009 Jul; 458(3):443-57. PubMed ID: 19184093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wide complex tachycardia in dialysis patients is not always hyperkalemia.
    Hoang K; Pazderka P; Hakmeh W
    Am J Emerg Med; 2022 Feb; 52():267.e5-267.e7. PubMed ID: 34391584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long QT syndrome with a de novo CALM2 mutation in a 4-year-old boy.
    Fujita S; Nakagawa R; Futatani T; Igarashi N; Fuchigami T; Saito S; Ohno S; Horie M; Hatasaki K
    Pediatr Int; 2019 Sep; 61(9):852-858. PubMed ID: 31283864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. QT interval prolongation and torsade de pointes: Synergistic effect of flecainide and H1 receptor antagonists.
    Acosta-Materán C; Díaz-Oliva E; Fernández-Rodríguez D; Hernández-Afonso J
    J Pharmacol Pharmacother; 2016; 7(2):102-5. PubMed ID: 27440957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.